Delivery of Anxiety Disorder Treatment in Addictions Centers
- Conditions
- Anxiety DisordersSubstance Use Disorders
- Registration Number
- NCT01764698
- Lead Sponsor
- University of California, Los Angeles
- Brief Summary
Anxiety disorders are highly prevalent among those with substance use disorders, but the majority of addictions treatment centers provide little to no evidence-based treatment for anxiety disorders. Furthermore, tension reduction models suggest that treating anxiety should also improve substance use outcomes. This study is aimed at improving symptoms for people who have substance use and anxiety problems. The study is comparing regular Intensive Outpatient treatment for addiction to Intensive Outpatient treatment for addiction plus treatment for anxiety disorders. Clinicians at a community addictions clinic will participate by receiving training in delivering cognitive behavioral therapy for anxiety disorders and will deliver the treatment to the patient participants. They will also complete some questionnaires. Patient participants will be asked to complete a baseline assessment. Those who are eligible will be randomly assigned to one of the two treatment groups. Those who are assigned to addiction treatment as usual will continue their regular care at the Matrix Institute. Participants who are assigned to also receive the anxiety treatment will be asked to participate in 6, 90-min treatment sessions and an orientation session. All participants will be asked to complete post-treatment and follow-up assessments. The assessments should take approximately 1 hour, and the follow-up assessment will be completed 6 months after treatment is over. It is hypothesized that those who get the additional anxiety disorder treatment will show greater improvement in anxiety and substance use outcomes than those who get Intensive Outpatient Program without the anxiety disorder treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 98
- 18-60 years old
- speak English
- meet diagnostic criteria for at least one anxiety disorder
- score at least an 8 on the OASIS (see Assessments), indicating at least moderate but clinically significant anxiety symptoms
- be enrolled in the Intensive Outpatient Program (IOP) at the Matrix Institute (community partner)
- meet diagnostic criteria for substance abuse or dependence
- have unstable medical conditions
- marked cognitive impairment
- active suicidal intent or plan
- active psychosis
- unstable Bipolar I disorder.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Brief Symptom Inventory baseline, 6 weeks, 6 months Change over time is being assessed.
Timeline Follow Back baseline, 6 week, 6 month Change over time is being assessed
Overall Anxiety Severity and Impairment Scale baseline, 6 week, 6 month Change over time is being assessed.
- Secondary Outcome Measures
Name Time Method Social Phobia Inventory baseline, 6 week, 6 month Change over time is being assessed.
Posttraumatic Stress Disorder Checklist baseline, 6 week, 6 month Change over time is being assessed.
urine toxicology screen baseline, 6 week, 6 month Change over time is being assessed.
Patient Health Questionnaire-8 baseline, 6 week, 6 month brief depression measure; Change over time is being assessed.
Anxiety Sensitivity Index baseline, 6 week, 6 month Change over time is being assessed.
Panic Disorder Severity Scale baseline, 6 week, 6 month Change over time is being assessed.
Penn State Worry Questionnaire baseline, 6 week, 6 month Change over time is being assessed.
Trial Locations
- Locations (2)
Matrix Institute on Addictions
🇺🇸Los Angeles, California, United States
University of California-Los Angeles, Department of Psychiatry and Biobehavioral Sciences
🇺🇸Los Angeles, California, United States
Matrix Institute on Addictions🇺🇸Los Angeles, California, United States